The Food and Drug Administration (FDA) ruled Tuesday that a key drug in popular decongestants is ineffective, which one Canadian group of doctors has known for years. U.S. FDA allows over-the ...

Join our comprehensive FDA regulatory course to navigate submissions for INDs, NDAs, ANDAs, and 505(b)(2). Gain insights into FDA processes, recent changes, and strategic needs, featuring expert-led ...

The Expanded Decision Tree chemical toxicity and risk screening tool was evaluated through external peer-review, and FDA will ...

The Food and Drug Administration on Monday named a longtime pharmaceutical executive to run the agency’s drug program, the ...

Earlier this week, two new leaders of the US Food and Drug Administration published a list of priorities for the agency. Both Marty Makary and Vinay Prasad are controversial figures in the science ...